25805 Ixekizumab provides more durable improvements in skin clearance, itch, and quality of life than guselkumab in patients with moderate-to-severe psoriasis: 24-week results from IXORA-R

Saved in:
Bibliographic Details
Published inJournal of the American Academy of Dermatology Vol. 85; no. 3; p. AB11
Main Authors Jarell, Abel, Smith, Stacy, Gallo, Gaia, Renda, Lisa, Burge, Russel, Zhu, Baojin, Guo, Jiaying, Blue, Emily K., Rosmarin, David
Format Journal Article
LanguageEnglish
Published Elsevier Inc 01.09.2021
Online AccessGet full text

Cover

More Information
ISSN:0190-9622
1097-6787
DOI:10.1016/j.jaad.2021.06.070